Scynexis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCYNEXIS, and when can generic versions of SCYNEXIS drugs launch?
SCYNEXIS has one approved drug.
There are five US patents protecting SCYNEXIS drugs.
There are thirty-eight patent family members on SCYNEXIS drugs in twenty-four countries.
Drugs and US Patents for Scynexis
International Patents for Scynexis Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2011530593 | ⤷ Try a Trial |
Portugal | 3247711 | ⤷ Try a Trial |
European Patent Office | 3661503 | ⤷ Try a Trial |
Portugal | 3661503 | ⤷ Try a Trial |
European Patent Office | 3247711 | ⤷ Try a Trial |
Lithuania | 3661503 | ⤷ Try a Trial |
Hungary | E058721 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.